Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Baxter International is a medical instruments & supplies business based in the US. Baxter International stocks (BAX.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $41.34 – an increase of 1.55% over the previous week. Baxter International employs 60,000 staff and has a trailing 12-month revenue of around $15.1 billion.
Finder Award
Interactive Brokers
National Bank Direct Brokerage
| Latest market close | $41.97 |
|---|---|
| 52-week range | $37.08 - $71.85 |
| 50-day moving average | $42.91 |
| 200-day moving average | $48.61 |
| Wall St. target price | $50.71 |
| PE ratio | N/A |
| Dividend yield | $1.16 (2.81%) |
| Earnings per share (TTM) | $-4.94 |
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $41.97 from 2023-06-09
| 1 week (2023-06-02) | 1.55% |
|---|---|
| 1 month (2023-05-10) | -4.27% |
| 3 months (2023-03-10) | 10.39% |
| 6 months (2022-12-09) | -19.87% |
| 1 year (2022-06-10) | -42.60% |
|---|---|
| 2 years (2021-06-10) | -50.09% |
| 3 years (2020-06-10) | 86.84 |
| 5 years (2018-06-08) | 74.78 |
Valuing Baxter International stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Baxter International's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
| Revenue TTM | $15.1 billion |
|---|---|
| Operating margin TTM | 11.64% |
| Gross profit TTM | $6 billion |
| Return on assets TTM | 3.59% |
| Return on equity TTM | -32.52% |
| Profit margin | -16.34% |
| Book value | $11.62 |
| Market capitalisation | $20.9 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Baxter International.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 24.49
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Baxter International's overall score of 24.49 (as at 12/31/2018) is nothing to write home about – landing it in it in the 47th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Baxter International is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 1.01/100
Baxter International's environmental score of 1.01 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Baxter International is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 16.22/100
Baxter International's social score of 16.22 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Baxter International is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 6.28/100
Baxter International's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Baxter International is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Baxter International scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Baxter International hasn't always managed to keep its nose clean.
Dividend payout ratio: 36.71% of net profits
Recently Baxter International has paid out, on average, around 36.71% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.81% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Baxter International shareholders could enjoy a 2.81% return on their shares, in the form of dividend payments. In Baxter International's case, that would currently equate to about $1.16 per share.
While Baxter International's payout ratio might seem fairly standard, it's worth remembering that Baxter International may be investing much of the rest of its net profits in future growth.
Baxter International's most recent dividend payout was on 2 July 2023. The latest dividend was paid out to all shareholders who bought their shares by 31 May 2023 (the "ex-dividend date").
Baxter International's shares were split on a 1841:1000 basis on 30 June 2015. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1841 shares. This wouldn't directly have changed the overall worth of your Baxter International shares – just the quantity. However, indirectly, the new 45.7% lower share price could have impacted the market appetite for Baxter International shares which in turn could have impacted Baxter International's share price.
Over the last 12 months, Baxter International's shares have ranged in value from as little as $37.0791 up to $71.8518. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Baxter International's is 0.5647. This would suggest that Baxter International's shares are less volatile than average (for this exchange).
Baxter International Inc. , through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries.
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
The best stock trading app for beginners is easy to use and offers free trades.
Read more…
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…From personal and payday loans to lines of credit, compare loans for bad credit in Edmonton.
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
This guide provides step-by-step instructions on how to buy Pepe, lists some exchanges where you can get it and provides daily price data on (PEPE).
This guide provides step-by-step instructions on how to buy Arbitrum, lists some exchanges where you can get it and provides daily price data on (ARB).
This guide provides step-by-step instructions on how to buy SSV Network, lists some exchanges where you can get it and provides daily price data on (SSV).
This guide provides step-by-step instructions on how to buy USDD, lists some exchanges where you can get it and provides daily price data on (USDD).
This guide provides step-by-step instructions on how to buy Blur, lists some exchanges where you can get it and provides daily price data on (BLUR).
This guide provides step-by-step instructions on how to buy FLOKI Inu, lists some exchanges where you can get it and provides daily price data on (FLOKI).
This guide provides step-by-step instructions on how to buy Aptos, lists some exchanges where you can get it and provides daily price data on (APT).
This guide provides step-by-step instructions on how to buy EthereumPoW, lists some exchanges where you can get it and provides daily price data on (ETHW).
